KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Other Non-Current Assets (2016 - 2025)

Elevance Health (ELV) has disclosed Other Non-Current Assets for 17 consecutive years, with $2.8 billion as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Assets rose 6.68% to $2.8 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $2.8 billion, a 6.68% increase, with the full-year FY2024 number at $2.1 billion, up 8.8% from a year prior.
  • Other Non-Current Assets was $2.8 billion for Q3 2025 at Elevance Health, up from $2.6 billion in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $2.8 billion in Q3 2025 to a low of $1.6 billion in Q1 2021.
  • A 5-year average of $2.1 billion and a median of $2.1 billion in 2022 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: fell 14.73% in 2021, then grew 20.89% in 2024.
  • Elevance Health's Other Non-Current Assets stood at $1.7 billion in 2021, then dropped by 1.86% to $1.7 billion in 2022, then increased by 16.6% to $2.0 billion in 2023, then grew by 8.8% to $2.1 billion in 2024, then increased by 29.77% to $2.8 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Other Non-Current Assets are $2.8 billion (Q3 2025), $2.6 billion (Q2 2025), and $2.4 billion (Q1 2025).